Neuralink gains approval for brain chip trial in Canada

Neuralink has received approval to begin its first clinical trial in Canada for a brain chip designed to help paralyzed individuals control digital devices with their thoughts. The trial will assess the safety and functionality of the implant. The University Health Network in Toronto will conduct the neurosurgical procedures for the trial. In the U.S., Neuralink has already implanted the device in two patients, with one successfully using it for activities like gaming and 3D design. Founded in 2016 by Elon Musk, Neuralink is also developing a brain chip interface that could help restore movement and communication for disabled patients. The company recently received a "breakthrough device" designation from the U.S. FDA for its vision-restoring implant.